Category:

EXECUTIVES

Curiteva Adds Steve Cichy as Strategic Advisor and Erik Erbe, PhD, as Vice President of Clinical and Research

Curiteva adds two additional industry experts to help strategically lead the company and the development of its novel technology for the medical device industry.

James R. Tobin, Former CEO of Boston Scientific, Joins Xenter, Inc. Board of Directors to Assist in Advance of Device/Data/Drug Technologies

Prior to joining Xenter, Tobin served as President and Chief Executive Officer of Boston Scientific from March 1999 to July 2009, during which time the company’s revenues grew from more than $2 billion to more than $8 billion.

Christine Lind Appointed VP of Commercial NDA Group

Christine Lind has 20 years’ experience in a variety of roles within the Life Science sector.

Gregg F Martin, Retired Army Major General, Joins SoldierStrong Advisory Board

Gregg F Martin is a combat veteran, bipolar survivor, Airborne-Ranger-Engineer qualified soldier and Army strategist, who served on active duty for 36 years.

Nanoscope Therapeutics Announces New Clinical Advisory Board Appointments

President and Co-Founder Samarendra Mohanty, Ph.D. said, "We are honored to have such distinguished clinical experts in retinal disorders join us as advisers. Their guidance will be invaluable as we pioneer gene therapies to reprogram retinal cells and make them functionally active to regain vision."

Linda Psaras Is Promoted to Vice President of Sales and Marketing of MedSupply

Psaras breaks barriers as MedSupply’s first vice president, strengthening its commitment to superior service and offering innovative, cost-effective products.

David J. Vigerust, MS., PhD Named Chief Scientific Officer of Spectrum Solutions

Vigerust has founded, led as CEO, and previously served as chief scientific officer for a number of progressive life science and advanced biotech companies.

Randy D. Chatman Named New CEO of ThermoTek: 25 Years of Medical Device Operating Experience

Prior to joining ThermoTek, Chatman served as the Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access for Wright Medical Group, a global medical device company focused on extremities and biologics which recently sold to Stryker for $4.7 billion.

Amit Rushi Is Appointed to the Role of Chief Commercial Office of Bodyport

Amit Rushi will serve as part of the executive team and prepare the organization for commercialization and growth.
Medical Device News Magazinespot_img